Publication:
Antimetabolite cancer drug gemcitabine selectively impacts preantral and antral follicle cohorts in the ovary as evidenced by quantitatively histomorphometric, hormonal and cell viability markers

dc.contributor.coauthorN/A
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.kuauthorKılıç, Yağmur
dc.contributor.kuauthorŞahin, Gizem Nur
dc.contributor.kuauthorKaranfil, Işıl
dc.contributor.kuauthorEryılmaz, Baldan
dc.contributor.kuauthorYılmaz, Pelinsu
dc.contributor.kuauthorÖzkanbaş, Necmettin Can
dc.contributor.kuauthorÖktem, Özgür
dc.contributor.kuprofileUndergraduate Student
dc.contributor.kuprofilePhD Student
dc.contributor.kuprofileUndergraduate Student
dc.contributor.kuprofileUndergraduate Student
dc.contributor.kuprofileUndergraduate Student
dc.contributor.kuprofileUndergraduate Student
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.schoolcollegeinstituteGraduate School of Health Sciences
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokid102627
dc.date.accessioned2024-11-09T23:27:58Z
dc.date.issued2014
dc.description.abstractN/A
dc.description.indexedbyWoS
dc.description.openaccessNO
dc.description.volume29
dc.identifier.doiN/A
dc.identifier.eissn1460-2350
dc.identifier.issn0268-1161
dc.identifier.urihttps://hdl.handle.net/20.500.14288/11806
dc.identifier.wos359745300393
dc.keywordsN/A
dc.languageEnglish
dc.publisherOxford Univ Press
dc.sourceHuman Reproduction
dc.subjectObstetrics
dc.subjectGynecology
dc.subjectReproductive biology
dc.titleAntimetabolite cancer drug gemcitabine selectively impacts preantral and antral follicle cohorts in the ovary as evidenced by quantitatively histomorphometric, hormonal and cell viability markers
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.authoridN/A
local.contributor.authoridN/A
local.contributor.authoridN/A
local.contributor.authoridN/A
local.contributor.authoridN/A
local.contributor.authoridN/A
local.contributor.authorid0000-0003-1966-3886
local.contributor.kuauthorKılıç, Yağmur
local.contributor.kuauthorŞahin, Gizem Nur
local.contributor.kuauthorKaranfil, Işıl
local.contributor.kuauthorEryılmaz, Baldan
local.contributor.kuauthorYılmaz, Pelinsu
local.contributor.kuauthorÖzkanbaş, Necmettin Can
local.contributor.kuauthorÖktem, Özgür

Files